Is the Spanish Inheritance and Gift Tax incompatible with the free movement of workers and capital?: The reasoned opinion of the EU Commission IP/10/513

The aim of my speech is answering to the question if the Spanish Inheritance and Gift Tax is incompatible with the free movement of workers and capital. We are going to pay special attention to the European Commission’s request to Spain to change its Inheritance and Gift Tax provisions for Non-Residents or Assets held abroad. In order to answer to the question mentioned above five points will be explained. At first place I am going to describe the infrengement procedure established in the Article 258 that the EU Commission can follow when a Member State doesn’t comply with Community Law. At second place, we are going to explain what is the content of the EU Commission delivered on 5th of may 2010 regarding the spanish Inheritance and Gift Tax. Then, we will analise what establishes the Community Law regarding the freedom of workers and capital and how they are understood by the EU Court of Justice in similar cases. Finally, we are going to provide possible amendments that Spain could undertake.

Dendritic cells exposed to MVA-based HIV-1 vaccine induce highly functional HIV-1-specific CD8+ T cell responses in HIV-1-infected individuals

Currently, MVA virus vectors carrying HIV-1 genes are being developed as HIV-1/AIDS prophylactic/therapeutic vaccines. Nevertheless, little is known about the impact of these vectors on human dendritic cells (DC) and their capacity to present HIV-1 antigens to human HIV-specific T cells. This study aimed to characterize the interaction of MVA and MVA expressing the HIV-1 genes Env-Gag-Pol-Nef of clade B (referred to as MVA-B) in human monocyte-derived dendritic cells (MDDC) and the subsequent processes of HIV-1 antigen presentation and activation of memory HIV-1-specific T lymphocytes. For these purposes, we performed ex vivo assays with MDDC and autologous lymphocytes from asymptomatic HIV-infected patients. Infection of MDDC with MVA-B or MVA, at the optimal dose of 0.3 PFU/MDDC, induced by itself a moderate degree of maturation of MDDC, involving secretion of cytokines and chemokines (IL1-ra, IL-7, TNF-α, IL-6, IL-12, IL-15, IL-8, MCP-1, MIP-1α, MIP-1β, RANTES, IP-10, MIG, and IFN-α). MDDC infected with MVA or MVA-B and following a period of 48 h or 72 h of maturation were able to migrate toward CCL19 or CCL21 chemokine gradients. MVA-B infection induced apoptosis of the infected cells and the resulting apoptotic bodies were engulfed by the uninfected MDDC, which cross-presented HIV-1 antigens to autologous CD8+ T lymphocytes. MVA-B-infected MDDC co-cultured with autologous T lymphocytes induced a highly functional HIV-specific CD8+ T cell response including proliferation, secretion of IFN-γ, IL-2, TNF-α, MIP-1β, MIP-1α, RANTES and IL-6, and strong cytotoxic activity against autologous HIV-1-infected CD4+ T lymphocytes. These results evidence the adjuvant role of the vector itself (MVA) and support the clinical development of prophylactic and therapeutic anti-HIV vaccines based on MVA-B.

Dendritic cells exposed to MVA-based HIV-1 vaccine induce highly functional HIV-1-specific CD8+ T cell responses in HIV-1-infected individuals

Currently, MVA virus vectors carrying HIV-1 genes are being developed as HIV-1/AIDS prophylactic/therapeutic vaccines. Nevertheless, little is known about the impact of these vectors on human dendritic cells (DC) and their capacity to present HIV-1 antigens to human HIV-specific T cells. This study aimed to characterize the interaction of MVA and MVA expressing the HIV-1 genes Env-Gag-Pol-Nef of clade B (referred to as MVA-B) in human monocyte-derived dendritic cells (MDDC) and the subsequent processes of HIV-1 antigen presentation and activation of memory HIV-1-specific T lymphocytes. For these purposes, we performed ex vivo assays with MDDC and autologous lymphocytes from asymptomatic HIV-infected patients. Infection of MDDC with MVA-B or MVA, at the optimal dose of 0.3 PFU/MDDC, induced by itself a moderate degree of maturation of MDDC, involving secretion of cytokines and chemokines (IL1-ra, IL-7, TNF-α, IL-6, IL-12, IL-15, IL-8, MCP-1, MIP-1α, MIP-1β, RANTES, IP-10, MIG, and IFN-α). MDDC infected with MVA or MVA-B and following a period of 48 h or 72 h of maturation were able to migrate toward CCL19 or CCL21 chemokine gradients. MVA-B infection induced apoptosis of the infected cells and the resulting apoptotic bodies were engulfed by the uninfected MDDC, which cross-presented HIV-1 antigens to autologous CD8+ T lymphocytes. MVA-B-infected MDDC co-cultured with autologous T lymphocytes induced a highly functional HIV-specific CD8+ T cell response including proliferation, secretion of IFN-γ, IL-2, TNF-α, MIP-1β, MIP-1α, RANTES and IL-6, and strong cytotoxic activity against autologous HIV-1-infected CD4+ T lymphocytes. These results evidence the adjuvant role of the vector itself (MVA) and support the clinical development of prophylactic and therapeutic anti-HIV vaccines based on MVA-B.

Dendritic cells exposed to MVA-based HIV-1 vaccine induce highly functional HIV-1-specific CD8+ T cell responses in HIV-1-infected individuals

Currently, MVA virus vectors carrying HIV-1 genes are being developed as HIV-1/AIDS prophylactic/therapeutic vaccines. Nevertheless, little is known about the impact of these vectors on human dendritic cells (DC) and their capacity to present HIV-1 antigens to human HIV-specific T cells. This study aimed to characterize the interaction of MVA and MVA expressing the HIV-1 genes Env-Gag-Pol-Nef of clade B (referred to as MVA-B) in human monocyte-derived dendritic cells (MDDC) and the subsequent processes of HIV-1 antigen presentation and activation of memory HIV-1-specific T lymphocytes. For these purposes, we performed ex vivo assays with MDDC and autologous lymphocytes from asymptomatic HIV-infected patients. Infection of MDDC with MVA-B or MVA, at the optimal dose of 0.3 PFU/MDDC, induced by itself a moderate degree of maturation of MDDC, involving secretion of cytokines and chemokines (IL1-ra, IL-7, TNF-α, IL-6, IL-12, IL-15, IL-8, MCP-1, MIP-1α, MIP-1β, RANTES, IP-10, MIG, and IFN-α). MDDC infected with MVA or MVA-B and following a period of 48 h or 72 h of maturation were able to migrate toward CCL19 or CCL21 chemokine gradients. MVA-B infection induced apoptosis of the infected cells and the resulting apoptotic bodies were engulfed by the uninfected MDDC, which cross-presented HIV-1 antigens to autologous CD8+ T lymphocytes. MVA-B-infected MDDC co-cultured with autologous T lymphocytes induced a highly functional HIV-specific CD8+ T cell response including proliferation, secretion of IFN-γ, IL-2, TNF-α, MIP-1β, MIP-1α, RANTES and IL-6, and strong cytotoxic activity against autologous HIV-1-infected CD4+ T lymphocytes. These results evidence the adjuvant role of the vector itself (MVA) and support the clinical development of prophylactic and therapeutic anti-HIV vaccines based on MVA-B.

Dendritic cells exposed to MVA-based HIV-1 vaccine induce highly functional HIV-1-specific CD8+ T cell responses in HIV-1-infected individuals

Currently, MVA virus vectors carrying HIV-1 genes are being developed as HIV-1/AIDS prophylactic/therapeutic vaccines. Nevertheless, little is known about the impact of these vectors on human dendritic cells (DC) and their capacity to present HIV-1 antigens to human HIV-specific T cells. This study aimed to characterize the interaction of MVA and MVA expressing the HIV-1 genes Env-Gag-Pol-Nef of clade B (referred to as MVA-B) in human monocyte-derived dendritic cells (MDDC) and the subsequent processes of HIV-1 antigen presentation and activation of memory HIV-1-specific T lymphocytes. For these purposes, we performed ex vivo assays with MDDC and autologous lymphocytes from asymptomatic HIV-infected patients. Infection of MDDC with MVA-B or MVA, at the optimal dose of 0.3 PFU/MDDC, induced by itself a moderate degree of maturation of MDDC, involving secretion of cytokines and chemokines (IL1-ra, IL-7, TNF-α, IL-6, IL-12, IL-15, IL-8, MCP-1, MIP-1α, MIP-1β, RANTES, IP-10, MIG, and IFN-α). MDDC infected with MVA or MVA-B and following a period of 48 h or 72 h of maturation were able to migrate toward CCL19 or CCL21 chemokine gradients. MVA-B infection induced apoptosis of the infected cells and the resulting apoptotic bodies were engulfed by the uninfected MDDC, which cross-presented HIV-1 antigens to autologous CD8+ T lymphocytes. MVA-B-infected MDDC co-cultured with autologous T lymphocytes induced a highly functional HIV-specific CD8+ T cell response including proliferation, secretion of IFN-γ, IL-2, TNF-α, MIP-1β, MIP-1α, RANTES and IL-6, and strong cytotoxic activity against autologous HIV-1-infected CD4+ T lymphocytes. These results evidence the adjuvant role of the vector itself (MVA) and support the clinical development of prophylactic and therapeutic anti-HIV vaccines based on MVA-B.

¡Hasta la última papeleta! Las elecciones italianas del 9 y 10 de abril de 2006

La oposición de centro-izquierda ha ganado las elecciones italianas de 9/10 abril 2006 por solamente 24.000 votos, lo 0,6 por ciento de 38 millones de electores. Ha ganado también la mayoría de los escaños en el Senado gracias al voto de los italianos en el extranjero. Como la mayoría en el Senado es de solamente dos escaños y como el Senado tiene los mismos poderes de la otra cámara, el Gobierno Prodi, que ha sustituido después de cinco años lo de Berlusconi, puede tener una vida muy difícil. Cuanto al sistema de partido salido de las elecciones, eso se confirma el modelo de “bipolarismo fragmentado”: se ha realizado la alternancia en el poder por la tercera vez consecutiva y se han mantenido dentro de las dos coaliciones muchos partidos tal vez conflictivos entre ellos.

Sistemes de formació en presseguer: avaluació i resultats econòmics als 10 anys d’implantació

El presseguer es una espècie molt important en la fructicultura de Lleida, en constant increment i sotmesa a forts canvis de mercat en els darrers anys. Aquesta situació ha fet que les decisions que es prenen abans de la plantació com ara la densitat i el sistema de formació siguin encara més importants, ja que condicionen la inversió inicial i la rendibilitat futura. A més a més, en el cas dels sistemes de formació, aquests tenen una forta repercussió en la necessitat de mà d’obra i de maquinaria per les feines normals de cultiu, fet que condiciona o be condicionat pel tipus d’explotació que tenim. Per tant és d’interès analitzar diferents sistemes de formació per treure’n el màxim rendiment econòmic. Una de les tendències més generalitzades en els darrers anys és la reducció del volum total del arbre, utilitzant formes en volum de poca alçada. Els objectius perseguits en aquests sistemes són tenir un baix cost d’inversió i de mà d’obra, podent realitzar la major part de les tasques des de terra, sense renunciar però a una alta producció i qualitat però, sobretot, una millor rendibilitat econòmica. Conscients de la importància que té l’elecció del sistema de formació en l’èxit econòmic de la plantació, l’any 1995 l’IRTA-Estació Experimental de Lleida va començar un assaig de comparació de diferents sistemes de producció en presseguer a la finca de Gimenells. En aquest assaig, i durant 10 anys, s’han controlat els temps de treball en cada una de les feines anuals, així com les produccions, calibres i qualitats obtingudes. Aquesta tasca ens ha permès l’estudi econòmic dels sistemes que s’exposa a continuació.

Comportament agronòmic de portaempelts de pomera: resultats als 10 anys d’implantació

Estudi del comportament agronòmic de 18 portaempelts de pomera adaptables a les principals varietats conreades a Catalunya.

Comportament agronòmic de portaempelts de presseguer: resultats als 10 anys d'implantació

Estudi del comportament agronòmic de 22 portaempelts de presseguer d’interès per les principals varietats conreades a Catalunya.

Creació d'IP Cores en una plataforma NIOS: metodologia de disseny

NIOS és el processador que Altera empra en els seus dissenys SOC (System On Chip). Per tal de facilitar-ne el seu ús, Altera també proporciona una plataforma de desenvolupament SOPC (System On Programable Chip) que agilitza enormement el disseny d’aquests sistemes. Així doncs, aquest projecte està centrat en la definició metodològica per a la creació d'IP Cores en una plataforma NIOS.

Desplegament dels circuits dedicats de 1 i 10 Gbps entre el PIC i el CERN

Aquest projecte consisteix a realitzar el disseny i desplegament d'una connexió entre el Port d'Informació Científica (PIC) i el Consell Europeu per a la Recerca Nuclear (CERN) sobre un circuit dedicat amb una velocitat de transferència de 10 Gbps. En una primera fase el desplegament de la connexió es realitza sobre un circuit dedicat de 1 Gbps. El projecte implica la certificació dels circuits dedicats de 1 i 10 Gbps i el disseny dels plans d'actuació que han de permetre la integració de les noves connexions dins la xarxa i els serveis del PIC.